11th February 2015

Neurological Alliance Annual Meeting 2014

Annual General Meeting

The following matters were approved:

  • Minutes of the Annual General Meeting of Tuesday 26 November 2013
  • The Annual Report and Accounts 2013-14
  • The appointment of H.W. Fisher and Company as the Alliance’s Independent Examiners for the forthcoming year and the 2014-15 accounts

Please see here for the Annual Report and Accounts.

Trustee elections

Two trustees stepped down from the Board:

  • Sue Millman, Chief Executive, Ataxia UK
  • Angus Somerville, Chief Executive, Royal Hospital for Neurodisability

Many thanks go out to them both for their contributions as trustees of the Alliance and we look forward to continuing to work with them in other capacities in the future.

We are very pleased that all other trustees agreed to continue on in their roles for the forthcoming year and we welcome three new trustees to the Alliance:

  • Suzanne Dobson, Chief Executive, Tourette’s Action
  • Caroline Morrice, Chief Executive, Guillain-Barre and Associated Inflammatory Neuropathies
  • Mike Smeeton, Director of Health and Social Care, Sue Ryder.

Please see here for more information on our trustees.

Members’ meeting

Our members’ meeting brought together Chief Executives, regional representatives, service users and policy, public affairs and communication leads and corporate representatives from across our membership to discuss the main theme of the day: the use of data and intelligence to influence commissioning practice.

Speakers included the National Clinical Director for neurological conditions, Dr David Bateman, who looked at the progress made by neurology over the past 12 months and explored future opportunities linked to the development and publication of new sources of neurology data. James Seward of Public Health England discussed the work of the Neurology Intelligence Network and the development of new data and intelligence sources at the national level. Finally, Juliette Ashton discussed her work with local commissioners on behalf of the Epilepsy Society and Epilepsy Action, using local data to influence the development of improved care pathways for epilepsy. All three presentations were well-received and generated lively discussion, as well as raising awareness of the potential of new data and intelligence to drive up standards across neurological services.

Back to top